Press release
Cancer Immunotherapy Market is expected to reach US$ 261.74 billion by 2033 | Top key players - Merck, Bristol-Myers Squibb, AstraZeneca.
Cancer Immunotherapy Market
The Cancer Immunotherapy Market size reached US$ 137.70 billion in 2024 and is expected to reach US$ 261.74 billion by 2033, growing at a CAGR of 7.9% during the forecast period 2025-2033.
Cancer Immunotherapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/cancer-immunotherapy-market?sz
The Cancer Immunotherapy Market refers to the segment of the healthcare industry focused on therapies that harness and enhance the body's immune system to identify, target, and eliminate cancer cells. It includes immune checkpoint inhibitors, monoclonal antibodies, cancer vaccines, adoptive cell therapies, and cytokines, offering advanced, personalized, and less toxic treatment alternatives compared to conventional cancer therapies.
Recent Key Developments of USA and Japan:
USA:
July 18, 2025: University of Florida researchers develop an experimental mRNA vaccine that, when paired with immune checkpoint inhibitors, triggers a strong anti-tumor response in mice, with potential for a universal cancer vaccine.
April 1, 2025: A clinical trial led by the National Institutes of Health demonstrates a new form of tumor-infiltrating lymphocyte (TIL) therapy, combined with pembrolizumab, significantly improved effectiveness for patients with metastatic gastrointestinal cancers.
Japan
March 3, 2025: Researchers at the Japan Advanced Institute of Science and Technology (JAIST) developed magnetic nanoparticles that can be directed to tumors and heated with a laser to destroy cancer cells.
January 17, 2025: Chugai Pharmaceutical receives the Minister of Health, Labour and Welfare Award for its discovery of alectinib hydrochloride, a cancer drug for ALK-positive lung cancer.
Market Key Players:
Merck & Co., Inc.
Johnson & Johnson Services, Inc.
Bristol-Myers Squibb Company
AstraZeneca
Pfizer Inc.
F. Hoffmann-La Roche Ltd
Novartis AG
Kite Pharma, Inc.
Dendreon Pharmaceuticals LLC.
Amgen Inc.
Growth Forecast Projected:
The Global Cancer Immunotherapy Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Cancer Immunotherapy Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=cancer-immunotherapy-market
Market Segmentation:
By Type: Immune Checkpoint Inhibitors, Cytokines, Cancer Vaccines, Adoptive Cell Therapy, Other Immunotherapies.
By Indication: Non-Small Cell Lung Cancer (NSCLC), Melanoma, Colorectal Cancer, Renal Cell Carcinoma, Breast Cancer, Bladder Cancer, Others.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cancer-immunotherapy-market
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
➠ How big is the Cancer Immunotherapy market?
➠ Who are the key players in the Cancer Immunotherapy market?
➠ What is the projected growth rate of the Cancer Immunotherapy market?
➠ What is the market forecast for the Cancer Immunotherapy industry by 2033?
➠ Which region is estimated to dominate the Cancer Immunotherapy market through the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Immunotherapy Market is expected to reach US$ 261.74 billion by 2033 | Top key players - Merck, Bristol-Myers Squibb, AstraZeneca. here
News-ID: 4171926 • Views: …
More Releases from DataM Intelligence 4Market Research
Medical Tourism Market is expected to reach US$ 230.35 billion by 2033 | Top key …
Market Size and Growth:
The Global Medical Tourism Market size reached US$ 47.09 billion in 2024 and is expected to reach US$ 230.35 billion by 2033, growing at a CAGR of 19.4% during the forecast period 2025-2033.
Medical Tourism Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions…
CAR-T Cell Therapy Market is expected to reach US$ 20.4 billion by 2033 | Top ke …
Market Size and Growth:
The Global CAR-T Cell Therapy Market reached US$ 4.8 billion in 2024 and is expected to reach US$ 20.4 billion by 2033, growing at a CAGR of 16.3% during the forecast period 2025-2033.
CAR-T Cell Therapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
Hepatocellular Carcinoma Treatment Market is expected to reach US$ 1,964.88 mill …
Market Size and Growth:
The Hepatocellular Carcinoma Treatment Market size reached US$ 995.63 million in 2024 and is expected to reach US$ 1,964.88 million by 2033, growing at a CAGR of 7.4% during the forecast period 2025-2033.
Hepatocellular Carcinoma Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
Structural Heart Devices Market is expected to reach US$ 28.84 billion by 2033 | …
Market Size and Growth:
The Global Structural Heart Devices Market size reached US$ 14.79 billion in 2024 and is expected to reach US$ 28.84 billion by 2033, growing at a CAGR of 8.0% during the forecast period 2025-2033, according to DataM Intelligence report.
Structural Heart Devices Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
